Post Tagged with: "pediatrics"

Photo: Shutterstock

New Antibody Shows Promise for Preventing RSV in Infants

Thanks to a collaboration between the pharmaceutical company MedImmune and Geisel structural biologist Jason McLellan, PhD, a long-awaited vaccine to protect infants from RSV may soon become a reality. Their findings are featured as this month’s cover story in the journal Science Translational Medicine.

Classmates Sarah Donaldson MED’66 and Suzanne Boulter MED’66 (right) at the 2015 Geisel Alumni Awards Ceremony.  

Suzanne Boulter MED’66: Healthy Pursuits

Ask Suzanne Boulter MED’66 what she has been doing since she retired from clinical practice in 2010, and you won’t hear about a life of leisure. She is currently working on a nationwide American Academy of Pediatrics program called “Brush, Book, and Bed.”

NICU Admissions Increasing for Normal Birth Weight and Term Infants

NICU Admissions Increasing for Normal Birth Weight and Term Infants

A new Dartmouth study found that admission rates to neonatal intensive care units (NICUs) are increasing for newborns of all weights. In effect, NICUs are increasingly caring for normal, or near normal, birth weight and term infants. The study, recently published online by JAMA Pediatrics, raises questions about possible overuse of this highly specialized and expensive care for some newborns.

Drug Derived From Scorpion Venom Will Target Brain Cancer in Kids

Seattle Times – Quotes David Roberts, professor of surgery and neurology, on news that Seattle Children’s Hospital will be testing a new dye derived from scorpion venom that lights up cancer cells so surgeons can see — and remove — deadly brain tumors. Roberts and other colleagues have also been testing a similar drug compound, 5-aminolevulinic acid (5-ALA), which targets glial tumors.